참고문헌 (21)

1. J. Med. Chem. C. M. Bowman 14 206 1973 10.1021/jm00261a008 Bowman, C. M., Porter, T. H., Skelton, F. S. and Folkers, K., 5,8-Quinolinequinone analogs which inhibit mitochondrial succinoxidase.J. Med. Chem. 14, 206 (1973). 

   상세보기

2. A. C. Clark 1 1992 10.1007/978-1-4899-6729-9_1 New Approaches for Antifungal Drugs Clark, A. C., The need for new antifungal Drugs, In Fernandes, P. B. (Eds.),New Approaches for Antifungal Drugs. Birkhaeser, Boston, 1992, pp. 1-19. 

   

3. Lancet J. Dupouy-Camet 338 383 1991 10.1016/0140-6736(91)90514-P Dupouy-Camet, J., Paugam, A. and Tourte-Schaefer, C., Yeast susceptibility testing.Lancet, 338, 383 (1991). 

   상세보기

4. Antimicrob. Agents Chemother. M. A. Fisher 33 1042 1989 10.1128/AAC.33.7.1042 Fisher, M. A., Lee, P. G. and Tarry W. F., Fluconazole treatment of candidiasis in normal and diabetic rats.Antimicrob. Agents Chemother., 33, 1042-1045 (1989). 

   상세보기

5. Georgiev, V. S., Fungal infections and the search for antifungal agents, In Georgiev, V.S. (Ed),Antifungal Drugs. New York Academy of Sciences, New York, 198, pp. 1-4. 

6. Science N. H. Georgopapadakou 264 371 1994 10.1126/science.8153622 Georgopapadakou, N. H. and Walsh, J., Human mycoses: Drugs and targets for emerging pathogens.Science, 264, 371-373 (1994). 

   상세보기

7. Hudson, A. T., Atovaquone-A novel agent for the treatment of malaria, PCP and toxoplasmosis, In Bentley, P. H. and Ponsford, R. (Ed),Recent Advances in the Chemistry of Anti-infective Agents. Royal Society of Chemistry, 1992, pp. 322-335. 

8. Jeschke, P., Linder, W., Mueller, N. and Dehne, H. W., Fungicides based on amino-substituted quinolinequinones.Ger. Offen., DE 4,208,874 (1993). 

9. Jeschke, P., Linder, W., Mueller, N., Harder, A. and Mencke, N., New 6(7)amino-substituted-5,8-quinolinediones to combat endoparasites.Eur. Pat., Appl. EP 519,290 (1992). 

10. M. R. Mcginnis 198 1991 Antibiotics in Laboratory Medicine 3rd ed. Mcginnis M. R. and Rindali, M. G., Antifungal drug, In Lorian V. (Ed),Antibiotics in Laboratory Medicine. 3rd ed., Williams and Wilkins, Baltimore, 1991, pp. 198-256. 

11. Yakhak Hoeji Y. M. Park 40 4 1996 Park, Y. M., Kim, H. J., Kim, D. H., Lee, I. K. and Ryu, C. K., The evaluation ofin vivo antifungal activities of 6-[(N-4-fluoro)amino]-7-chloro-5,8-quinolinediones.Yakhak Hoeji, 40, 4-9 (1996). 

12. Antimicrob. Agents Chemother. J. H. Rex 39 1 1995 10.1128/AAC.39.1.1 Rex, J. H., Rinaldi, M. G. and Pfaller, M. A., Resistance ofCandida species to fluconazole.Antimicrob. Agents Chemother., 39, 1-8 (1995). 

    상세보기

13. Clin. Microbiol. Rev. J. H. Rex 6 367 1993 10.1128/CMR.6.4.367 Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. and Galgiani, J. N., Antifungal susceptibility testing.Clin. Microbiol. Rev., 6, 367-381 (1993). 

    상세보기

14. Arch. Biochem. Biophys. H. Roberts 191 306 1978 10.1016/0003-9861(78)90093-0 Roberts, H., Choo, W. M., Smith, S. C., Marzuki, S., Linnane, A. W., Porter, T. H. and Folkers, K., The site of inhibition of mitochondrial electron transfer by coenzyme Q analogs.Arch. Biochem. Biophys., 191, 306-315 (1978). 

    상세보기

15. Yakhak Hoeji C. K. Ryu 39 417 1995 Ryu, C. K., Kim, D. H., Yun, Y. P., Heo, M. Y., Lee, B. M., Jang, S. J., Kim, H. J. and Park, Y. M., The evaluation of in vivo antifungal activities and toxicities of 6-[(N-4-chlorophenyl)amino]-7-chloro-5,8-quinolinediones.Yakhak Hoeji, 39, 417-426 (1995). 

    원문보기 상세보기

16. Arch. Pharm. Res. C. K. Ryu 17 483 1994 10.1007/BF02979131 Ryu, C. K. and Kim, D. H., The antifungal susceptibility tests of 5,8-quinolinediones againstCandida sp.Arch. Pharm. Res., 17, 483-486 (1994a). 

    원문보기 상세보기

17. Arch. Pharm. Res. C. K. Ryu 17 139 1994 10.1007/BF02974248 Ryu, C. K. and Kim, H. J., The synthesis of 6-(N-arylamino)-7-chloro-5,8-quinolinedione derivatives for evaluation of antifungal activities.Arch. Pharm. Res., 17, 139-144 (1994b). 

    원문보기 상세보기

18. Clin. Infec. Diseases D. J. Sheehan 17 Suppl. 2 494 1993 10.1093/clinids/17.Supplement_2.S494 Sheehan, D. J., Espinel-Ingroff, A., Moor, D. J. and Webb, C. D., Antifungal susceptibility tests of yeasts: A brief overview.Clin. Infec. Diseases, 17(Suppl. 2), 494-500 (1993). 

    

19. Science S. Sternberg 266 1632 1994 10.1126/science.7702654 Sternberg, S., The emerging fungal threat.Science, 266, 1632-1634 (1994). 

    상세보기

20. Antimicrob. Agents Chemother. A. M. Sugar 38 371 1994 10.1128/AAC.38.2.371 Sugar A. M., Salibian, M. and Goldani, L. Z., Saperconazole therapy of murine disseminated candidiasis: Efficacy and interaction with amphotericin B.Antimicrob. Agents Chemother. 38, 371-373 (1994). 

    상세보기

21. Antimicrob. Agents Chemother. C. Viscoli 35 365 1991 10.1128/AAC.35.2.365 Viscoli, C. and Terragna, A., Fluconazole in the treatment of candidiasis in immunocompromised children.Antimicrob. Agents Chemother., 35, 365-367 (1991). 

    상세보기

저자의 다른 논문 :

유충규 (37) 김동현 (240) 이인경 (1) Kim, Sung-Hee (2)